(Q39571357)

13 September 2017

title

Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice (English)

1 reference

13 September 2017

1 reference

Eleftherios C Vamvakas

series ordinal

1

1 reference

13 September 2017

publication date

6 August 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

53

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

888-901

1 reference

The Function of Measurement in Modern Physical Science

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Multicomponent apheresis blood collection in the United States: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Current issues relating to the transfusion of stored red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Meta-analysis of clinical studies of the purported deleterious effects of "old" (versus "fresh") red blood cells: are we at equipoise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Pitfalls in the current published observational literature on the effects of red blood cell storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Safety of the blood supply in the United States: opportunities and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Activity-based costs of blood transfusions in surgical patients at four hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Estimating the cost of blood: past, present, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Implications of demographics on future blood supply: a population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Patient blood management: the pragmatic solution for the problems with blood transfusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

21 January 2018

Surgery without blood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Clinical practice guideline: red blood cell transfusion in adult trauma and critical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Red blood cell transfusion: a clinical practice guideline from the AABB*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Blood use in elective surgery: the Austrian benchmark study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Blood conservation in cardiac surgery: the Virginia Commonwealth University (VCU) experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The Impact of Blood Conservation on Outcomes in Cardiac Surgery: Is It Safe and Effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Delayed adverse reactions to blood donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Apheresis affects bone and mineral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The relationship of plasma transfusion from female and male donors with outcome after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

A solution to the problem of studying blood donor-related risk factors when patients have received multiple transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

How much residual plasma may cause TRALI?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Prion diseases are efficiently transmitted by blood transfusion in sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Emerging Infections, Transfusion Safety, and Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Risk management. Science and the precautionary principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

MicroRNAs in platelet production and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

QALYfying the value of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Thrombotic complications of erythropoiesis-stimulating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Adverse blood transfusion outcomes: establishing causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Duration of red-cell storage and complications after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The relationship of blood product ratio to mortality: survival benefit or survival bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

Trauma blood management: avoiding the collateral damage of trauma resuscitation protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03825.X

10.1111/J.1537-2995.2012.03825.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference